(Q46015607)

18 December 2017

title

Diuretic response in acute heart failure: clinical characteristics and prognostic significance. (English)

1 reference

18 December 2017

acute decompensated heart failure

main subject

heart failure

0 references

1 reference

7

1 reference

18 December 2017

Piotr Ponikowski

8

1 reference

18 December 2017

Gad Cotter

10

1 reference

18 December 2017

Beth A. Davison

11

1 reference

18 December 2017

John Cleland

12

1 reference

18 December 2017

Christopher M O'Connor

6

Christopher M O'Connor

1 reference

18 December 2017

9

John R Teerlink

1 reference

18 December 2017

Dirk J van Veldhuisen

4

Dirk J Van Veldhuisen

1 reference

18 December 2017

Hans L Hillege

17

Hans L Hillege

1 reference

18 December 2017

Adriaan A Voors

2

Adriaan A Voors

1 reference

18 December 2017

Michael M Givertz

13

Michael M Givertz

1 reference

18 December 2017

Howard C Dittrich

16

Howard C Dittrich

1 reference

18 December 2017

Mattia A.E. Valente

1

Mattia A E Valente

1 reference

18 December 2017

Daniel M Bloomfield

14

Daniel M Bloomfield

1 reference

18 December 2017

Kevin Damman

3

Kevin Damman

1 reference

18 December 2017

author name string

Barrie M Massie

5

1 reference

18 December 2017

Mona Fiuzat

15

1 reference

18 December 2017

language of work or name

1 reference

28 February 2014

1 reference

18 December 2017

published in

European Heart Journal

1 reference

18 December 2017

volume

35

1 reference

18 December 2017

issue

19

1 reference

18 December 2017

page(s)

1284-1293

1 reference

18 December 2017

Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE).

cites work

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU065

The EuroHeart Failure survey programme-- a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU065

Acute decompensated heart failure syndromes (ATTEND) registry. A prospective observational multicenter cohort study: rationale, design, and preliminary data

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU065

Relation between dose of loop diuretics and outcomes in a heart failure population: results of the ESCAPE trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU065

Relationship between heart failure treatment and development of worsening renal function among hospitalized patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU065

Heart failure, chronic diuretic use, and increase in mortality and hospitalization: an observational study using propensity score methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU065

Impact of diuretic dosing on mortality in acute heart failure using a propensity-matched analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU065

Diuretic resistance predicts mortality in patients with advanced heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU065

The association between high-dose diuretics and clinical stability in ambulatory chronic heart failure patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU065

ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU065

Effect of bolus injection versus continuous infusion of furosemide on diuresis and neurohormonal activation in patients with severe congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU065

Diuretic strategies in patients with acute decompensated heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU065

Cardiorenal syndrome type 1: pathophysiological crosstalk leading to combined heart and kidney dysfunction in the setting of acutely decompensated heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU065

Diuretic therapy and resistance in congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU065

Weight changes after hospitalization for worsening heart failure and subsequent re-hospitalization and mortality in the EVEREST trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU065

Markers of decongestion, dyspnea relief, and clinical outcomes among patients hospitalized with acute heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU065

Diuretic use in heart failure and outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU065

Design and rationale of the PROTECT study: a placebo-controlled randomized study of the selective A1 adenosine receptor antagonist rolofylline for patients hospitalized with acute decompensated heart failure and volume overload to assess treatment e

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU065

Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU065

Drawbacks and prognostic value of formulas estimating renal function in patients with chronic heart failure and systolic dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU065

Pharmacokinetics of furosemide in man after intravenous and oral administration. Application of moment analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU065

Early ultrafiltration in patients with decompensated heart failure and diuretic resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU065

The cardiorenal syndrome in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU065

The predictive value of short-term changes in hemoglobin concentration in patients presenting with acute decompensated heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU065

Potential effects of aggressive decongestion during the treatment of decompensated heart failure on renal function and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU065

Pathophysiological mechanisms contributing to renal dysfunction in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU065

Inflammation in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU065

Metabolic syndrome, insulin resistance, and roles of inflammation--mechanisms and therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU065

Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU065

Urinary proteins in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU065

Is worsening renal function an ominous prognostic sign in patients with acute heart failure? The role of congestion and its interaction with renal function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU065

Haemodynamic effects of rolofylline in the treatment of patients with heart failure and impaired renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU065

The safety of an adenosine A(1)-receptor antagonist, rolofylline, in patients with acute heart failure and renal impairment: findings from PROTECT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU065

Early dyspnoea relief in acute heart failure: prevalence, association with mortality, and effect of rolofylline in the PROTECT Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU065

Diuretic dosing in acute decompensated heart failure: lessons from DOSE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU065

Diuretics and ultrafiltration in acute decompensated heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU065

Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU065

Ultrafiltration in decompensated heart failure with cardiorenal syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU065

Effects of the Adenosine A1 Receptor Antagonist Rolofylline on Renal Function in Patients With Acute Heart Failure and Renal Dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU065

21 January 2018

Identifiers

DOI

10.1093/EURHEARTJ/EHU065

1 reference

18 December 2017

1 reference

18 December 2017